How Institutional Funds Moved on ANAB

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
EcoR1 Capital, LLC EcoR1 Capital, LLC increased this position by 22% ($437,030,013 -> $531,906,345). 2026-06-30
Woodline Partners LP Woodline Partners LP increased this position by 153% ($19,092,438 -> $48,398,445). 2026-06-30
MILLENNIUM MANAGEMENT LLC MILLENNIUM MANAGEMENT LLC increased this position by 107% ($26,375,223 -> $54,493,830). 2026-06-30
Apis Capital Advisors, LLC Apis Capital Advisors, LLC increased this position by 154% ($13,199,480 -> $33,547,500). 2026-06-30
Sofinnova Investments, Inc. Sofinnova Investments, Inc. increased this position by 142% ($13,768,111 -> $33,313,680). 2026-06-30
GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC increased this position by 209% ($9,052,680 -> $28,015,335). 2026-06-30
FIRST TRUST ADVISORS LP FIRST TRUST ADVISORS LP opened a new position worth $17,481,757. 2026-06-30
Coppell Advisory Solutions LLC Coppell Advisory Solutions LLC opened a new position worth $16,575,695. 2026-06-30

Which Funds Hold ANAB

Largest reported positions as of 2026-06-30.

FundValueShares
EcoR1 Capital, LLC $531,906,345 7,880,094
TANG CAPITAL MANAGEMENT LLC $89,834,333 1,330,879
VANGUARD CAPITAL MANAGEMENT LLC $61,170,728 906,233
Affinity Asset Advisors, LLC $55,762,358 826,109
Sanofi $55,479,398 821,917
MILLENNIUM MANAGEMENT LLC $54,493,830 807,316
Woodline Partners LP $48,398,445 717,014
683 Capital Management, LLC $44,550,001 660,000
Palo Alto Investors LP $40,735,508 603,489
GEODE CAPITAL MANAGEMENT, LLC $37,982,346 562,584

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Sanofi’s 13F Portfolio Moves, Tracked Quarter by Quarter

Table-style overview of Sanofi's 13F portfolio changes for the quarter ending June 30, 2026, showing new positions in AGMB, ODTX, and TRAX, increases in MGTX, NVAX, INBX, MPLT, ANAB, and QTTB, a reduction in IMRX, and an exit from Eledon.

This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more